SCHEMBL17429644

SCHEMBL17429644

COC(=O)c1ccc(C=CCc2cccc(C)c2)c(Br)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 1/20 0.45
▸ MAPT P10636 4/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ ALOX12 P18054 1/20 0.45
▸ P4HB P07237 1/20 0.44
▸ LOXL2 Q9Y4K0 1/20 0.44
▸ CYP4F2 P78329 2/20 0.43
▸ CYP4A11 Q02928 2/20 0.43
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.40
▸ MAOB P27338 1/20 0.40
▸ GPR17 Q13304 1/20 0.39
▸ CCNC P24863 1/20 0.39
▸ CDK8 P49336 1/20 0.39
▸ SLC7A5 Q01650 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17429650 0.90 NOTUM (0.47) NOTUMMAPTMEN1KMT2AALOX12
SCHEMBL17386255 0.90 LMNA (0.45) NOTUMMAPTMEN1KMT2AP4HB
SCHEMBL17386254 0.90 LMNA (0.45) NOTUMMAPTMEN1KMT2AP4HB
SCHEMBL17385993 0.85 NOTUM (0.42) NOTUMMAPTKMT2AP4HBCYP3A4
SCHEMBL17385992 0.85 NOTUM (0.42) NOTUMMAPTKMT2AP4HBCYP3A4
SCHEMBL17429642 0.76 CYP4A11 (0.52) NOTUMMAPTMEN1KMT2AALOX12
SCHEMBL5893588 0.73 NOTUM (0.50) NOTUMMAPTMEN1KMT2AP4HB
SCHEMBL5893599 0.73 NOTUM (0.50) NOTUMMAPTMEN1KMT2AP4HB
SCHEMBL8680186 0.73 MEN1 (0.55) MAPTMEN1KMT2ACYP3A4CYP2C9
SCHEMBL8327237 0.73 MEN1 (0.55) MAPTMEN1KMT2ACYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9643946-B2 Tricyclic compound and use thereof SK CHEMICALS CO., LTD. (KR) 2017-05-09 — — US disclosed
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF SK CHEMICALS CO., LTD. (KR) 2016-01-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF GPR65, GPR119, GPR35 NOTUM 1257/4885MAPT 2131/4885MEN1 2105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback